Osteoporosis
7 competing products in clinical development for Osteoporosis.
Pipeline by Phase
Pre-clinical1
Phase 22
Phase 33
Approved1
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| raloxifene + placebo | Eli Lilly | Approved | Completed | 85 |
| Teriparatide + Alendronate Sodium + Placebo + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| Teriparatide | Eli Lilly | Phase 3 | Completed | 77 |
| Teriparatide + Salmon Calcitonin | Eli Lilly | Phase 3 | Completed | 77 |
| Subcutaneous Teriparatide + Transdermal Teriparatide | Eli Lilly | Phase 2 | Completed | 52 |
| arzoxifene + Placebo | Eli Lilly | Phase 2 | Completed | 52 |
| Forteo | Eli Lilly | Pre-clinical | UNKNOWN | 23 |